Laboratory Corporation of America Holdings (NYSE:LH) went up by 1.36% during the previous trading session, and it is maintaining the win ahead of Monday’s trading session. The share price of the Diagnostics & Research giant went up by $172.59 to trade ended Monday trading at $170.27. This is up from the $170.27 price recorded on Thursday’s trading session. Thanks to this latest performance, LH is closer to the higher price 52-week target of $244.00 and further from the lowest price target of $183.00. Its performance from the start of the year has also been positive, with LH up by 2.02% year-to-date.
Laboratory Corporation of America Holdings (LH) started the day trading at $172.62 and recorded an intraday high of $173.98. It also recorded an intraday low of $171 during Monday’s trading session. Laboratory Corporation of America Holdings is a very active stock that recorded a trading volume that is less than -55.03% of the average daily trading volume on Monday. The stock’s trading volume on Monday was 670838, which is less than -55.03 of the total average daily trading volume of 1.04 million.
Laboratory Corporation of America Holdings (NYSE:LH) 2020 Performance Impressive
The increase in LH’s stock price on Monday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of LH currently stands at $196.36, which is higher than the current trading price of the stock by 12.11%. However, LH’s current trading price is -76.08% lower than the 52-week low price of $98.02. In terms of trading volume, Laboratory Corporation of America Holdings currently experienced healthy participation during the last trading session. 670838 shares of Laboratory Corporation of America Holdings were traded on the stock exchange on Monday, which is less than -55.03% of the 1.04 million average trading volume of the stock.
The performance of the stock has been positive over the past year. LH’s performance over the past one year has seen it plunge by -2.92%, while the stock has gone up by 3.21% in the last six months. The quarterly performance of LH currently stands at 52.32%, and it is down by -4.46% in the last month. The only positive figure was from the weekly performance, which currently reads 6.56%. At the time of writing LH’s report, the company has a total market cap of $16.46B, making it one of the largest publicly-traded companies in the world.Laboratory Corporation of America Holdings also has over 65000 employees all over the world.
LH Insider Activities
For Laboratory Corporation of America Holdings, insiders hold 94.40% of all company shares. The insider transactions over the past six months are up by 11.30%. During that period, insiders bought 121,652 shares in 42 transactions. In that same period, insiders sold 104,792 of their shares in 44 transactions. After these transactions, insiders at Laboratory Corporation of America Holdings now hold 619.16k shares, which is over 95.73% of the total company stocks. Institutional investors currently hold a large chunk of the LH shares, as they control 0.64% of the company’s total stock.
LH Fundamental Analysis
For Laboratory Corporation of America Holdings, the stock’s diluted earnings per share (EPS) stands at 3.25. In the coming year, analysts expect the EPS to be 13.41. The stock’s EPS growth this year is -7.70%, with analysts expecting almost a 1 growth in the earnings per share next week. In terms of revenue, Laboratory Corporation of America Holdings’s quarterly sales (YOY) is growing at 0.59, which is lower than the average annual revenue of 7.10% over the past half a decade.
The Return on Investment (ROI) on Laboratory Corporation of America Holdings’s stock currently stands at 7.50%. The gross margin of the company is 27.50%.
LH Analysts Prediction
The Mizuho also has a Buy rating for Laboratory Corporation of America Holdings, predicting the stock price to stay between $158 and $186. and Citigroup reiterate their Buy position on the stock ($204 and $214).
UBS and BofA/Merrill also believe that Laboratory Corporation of America Holdings’s stock is outperforming at the moment.
At the moment, Laboratory Corporation of America Holdings’s Total Debt to Equity ratio stands at 0.90, and they have a long-term Debt to Equity ratio of 0.84.
LH Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of LH currently stands at 2.55%, while the SMA50 is 2.39%. The biggest one is the SMA200, which is currently reading 4.09% ahead of Monday’s trading session. The Relative Strength Index of this stock is 57.17, while its price to earnings ratio (P/E) is 53.12.